You are here: Industry Insights > Drugs

News List

MIMETAS Contributes With Human Organ-on-Chip Data to IND Application by Argenx Biotech Newswire
July 12, 2024
MIMETAS announced an Investigational New Drug (IND) filing by argenx and was supported by data from MIMETAS.
New Progress of Key Chinese COVID-19 Drugs under Research PharmaSources/Xiaoyaowan
October 28, 2021
With the wide spread of Delta mutant worldwide, the COVID-19 infection situation is worrisome. In addition to vaccination for prevention, drug therapy can alleviate the disease deterioration...
Govt extends validity of import licence & registration certificate by six months expresspharma
November 30, 2020
With an aim to ensure the availability of medicines amidst the prevailing corona virus in the country, the government has given an extension of six months for the validity of import licence (Form-10).
Demand for repurposed drugs to continue even after launch of COVID-19 vaccines: Experts expresspharma
November 24, 2020
Due to the large size of the population in the country and anticipated challenges associated with the COVID-19 vaccine supply chain, it will take considerable time until the entire nation gets vaccinated.
Drug Safety Research Unit says repurposed drugs for COVID-19 still require a lot of testing europeanpharmaceuticalreview
November 19, 2020
The DSRU said that global collaboration would be required to successfully expedite the necessary safety and efficacy evaluations for repurposed drugs to be used in COVID-19 patients.
Fall clause does not apply on the sale of drugs which have an expiry date: DoP expresspharma
November 17, 2020
The Department of Pharmaceuticals (DoP) has issued a letter informing the Ministries/Departments involved in the procurement of drugs through agencies that fall clause does not apply on the sale of drugs, which have an expiry date.
Industry appreciate Cabinet sanction of Rs 15000 crores for pharma PLI scheme expresspharma
November 12, 2020
The industry has appreciated the cabinet’s approval of Rs 15000 crores for the Production Linked Incentive (PLI) scheme in the pharma sector.
Research finds 25 percent of drugs contain highly potent compounds europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
FDA Takes Actions to Help Lower Prescription Drug Prices americanpharmaceuticalreview
September 27, 2020
The U.S. Department of Health and Human Services and the U.S. Food and Drug Administration (FDA) took actions to help provide safe, effective, and more affordable drugs to American patients as part of the Safe Importation Action Plan ...
MSF urges government authorities to include patented drugs in upcoming NLEM expresspharma
September 15, 2020
Also recommends inclusion of different formulations of insulin in the upcoming NLEM.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page